SLXP up +2.02% percent right now. $SLXP High is at 95.46

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
SLXP up +2.02% percent right now. $SLXP High is at 95.46 and the Low 90.00 with current volume of 2,161,204.

Recent News posted below.

SLXP Salix Pharmaceuticals Recent Headline News

Wolf Popper LLP Announces Investigation on Behalf of Investors in Salix Pharmaceuticals Ltd.
PR Newswire - 1 hr 2 mins ago
Wolf Popper LLP is investigating potential claims on behalf of investors in Salix Pharmaceuticals Ltd. ("Salix" common stock (NASDAQ: SLXP) during the period May 10, 2013 through November 6, 2014, concerning possible violations of federal securities laws. Such investors are advised to contact Fei-Lu Qian at 877.370.7703 or fqian@wolfpopper.com.
SLXP: 94.00 (+2.53)

Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Salix Pharmaceuticals Ltd. -- SLXP
GlobeNewswire - 1 hr 30 mins ago
Morgan & Morgan announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Salix Pharmaceuticals Ltd. ("Salix" or the "Company" (Nasdaq:SLXP) securities between November 8, 2013 and November 6, 2014, inclusive (the "Class Period".
SLXP: 94.00 (+2.53)

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock
at The Street - Mon Nov 10, 8:51AM CST
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "dead cat bounce" (down big yesterday but up big today) candidate
SLXP: 94.00 (+2.53)

Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:35AM CST
Salix Pharmaceuticals SLXP has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
SLXP: 94.00 (+2.53)

Deadline in Lawsuit for Investors in Salix Pharmaceuticals, Ltd. (SLXP) Shares Announced by Shareholders Foundation
GlobeNewswire - Mon Nov 10, 8:30AM CST
The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Salix Pharmaceuticals, Ltd. (SLXP) over alleged Federal Securities Laws Violations by Salix Pharmaceuticals, Ltd.
SLXP: 94.00 (+2.53)

Downgrade Alert for Salix Pharmaceuticals (SLXP)
Comtex SmarTrend(R) - Mon Nov 10, 8:04AM CST
Salix Pharmaceuticals (NASDAQ:SLXP) was downgraded from Buy to Neutral at Mizuho today. The stock closed yesterday at $91.47 on volume of 25.8 million shares, above average daily volume of 2.0 million. In the past 52 weeks, shares of Salix Pharmaceuticals have traded between a low of $82.52 and a high of $172.98 and closed yesterday at $91.47, which is 11% above that low price. The 200-day and 50-day moving averages have moved 0.63% higher and 1.83% lower over the past week, respectively.
SLXP: 94.00 (+2.53)

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.38 (+0.06), YHOO: 49.14 (+0.59), MNST: 106.91 (-1.48), ANF: 28.50 (-1.00), SLXP: 94.00 (+2.53), FFIV: 126.05 (-0.61), AKS: 6.59 (-0.03), TWTR: 40.05 (-0.26), GDX: 17.76 (-0.88), FXF: 100.98 (-0.12)

Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Salix Pharmaceuticals, Ltd. (SLXP)
GlobeNewswire - Fri Nov 07, 10:12PM CST
Labaton Sucharow LLP ("Labaton Sucharow" filed a securities class action lawsuit on behalf of Woburn Retirement System in the U.S. District Court for the Southern District of New York. The lawsuit was filed on behalf of all persons or entities who, between November 8, 2013 and November 6, 2014, inclusive (the "Class Period", purchased or otherwise acquired the securities of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company" (Nasdaq:SLXP).
SLXP: 94.00 (+2.53)

SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO
Business Wire - Fri Nov 07, 9:00PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF", announces that KSF has commenced an investigation into Salix Pharmaceuticals Ltd. (Nasdaq: SLXP).
SLXP: 94.00 (+2.53)

Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - Fri Nov 07, 7:10PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Salix Pharmaceuticals Ltd. ("Salix" or the "Company" (NASDAQ: SLXP), concerning whether the board has breached its fiduciary duties to shareholders.
SLXP: 94.00 (+2.53)

Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 36.39 (-1.04), LCI: 51.27 (+1.10), AKRX: 35.24 (-1.35), AFSI: 50.52 (+0.63), EXPE: 85.99 (+0.88), FFIV: 126.05 (-0.61), SLXP: 94.00 (+2.53), MPWR: 44.71 (+0.02), TMH: 53.62 (-0.52), ATHM: 44.05 (+0.42)

Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.31 (+0.07), PRSC: 38.14 (-0.34), FNGN: 30.61 (-0.78), LACO: 6.95 (+0.04), MSON: 11.48 (-0.32), SLXP: 94.00 (+2.53), FNHC: 26.30 (+0.16), MDRX: 11.35 (-0.19), PCMI: 8.41 (+0.96), UBNT: 29.24 (+0.46), PFMT: 6.61 (-0.43), ICPT: 177.30 (+4.71), ANDE: 54.29 (-0.50), ACTA: 16.61 (+0.09)

Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws
Business Wire - Fri Nov 07, 4:23PM CST
The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" for possible violations of federal securities laws.
SLXP: 94.00 (+2.53)

Market News: Sears, Salix Pharmaceuticals, Walt Disney
at The Street - Fri Nov 07, 3:38PM CST
The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...
SLXP: 94.00 (+2.53), DIS: 89.17 (-0.83), SHLD: 40.47 (-2.34)

Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 195.29 (-0.71), VRX: 127.62 (+1.51), DVA: 74.52 (+0.03), GILD: 107.46 (+1.01), SLXP: 94.00 (+2.53), ICPT: 177.30 (+4.71), HUM: 132.52 (+1.94)

Look for Shares of Salix Pharmaceuticals to Potentially Rebound after Yesterday's 33.98% Sell Off
Comtex SmarTrend(R) - Fri Nov 07, 3:35PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $86.00 to a high of $96.00. Yesterday, the shares fell 34.0%, which took the trading range below the 3-day low of $134.40 on volume of 25.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLXP: 94.00 (+2.53)

Humana and Salix are big market movers
AP - Fri Nov 07, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
WFM: 47.65 (+0.84), TSLA: 241.66 (+1.46), FSLR: 52.21 (+1.92), RIG: 29.58 (-0.13), WWWW: 15.58 (+0.18), GNRC: 40.65 (-0.21), SLXP: 94.00 (+2.53), BRKR: 17.92 (+0.01), KATE: 30.09 (-0.28), GNW: 8.29 (-0.12), SHLD: 40.47 (-2.34), ANR: 2.66 (-0.25), MCO: 99.03 (+0.08), HUM: 132.52 (+1.94)

Dow, S&P 500 Flirt With Record, But Finish Just Off
at Investor's Business Daily - Fri Nov 07, 3:28PM CST
Stocks finished narrowly mixed Friday after the Dow Jones industrial average and the S&P 500 hit record intraday highs, then drifted off in the final hours of trading. The Nasdaq finished down 0.2%, the Dow climbed 0.1% and the S&P 500 was...
MNST: 106.91 (-1.48), SLXP: 94.00 (+2.53), DIS: 89.17 (-0.83)

Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data
at The Street - Fri Nov 07, 3:22PM CST
The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.
MNST: 106.91 (-1.48), FSLR: 52.21 (+1.92), SLXP: 94.00 (+2.53), AKS: 6.58 (-0.04), SHLD: 40.47 (-2.34), VSAT: 62.65 (-2.74)

Why Salix Pharmaceuticals Ltd. Stock Was Throttled
Sean Williams, The Motley Fool - Motley Fool - Fri Nov 07, 2:45PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Salix Pharmaceuticals , a biopharmaceutical company...
SLXP: 94.00 (+2.53)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 206

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 0

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 7

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Cat Holdings Faces Class Action Lawsuit from Investors

Updated Category News Views 209

Overview of the Class Action Against Red Cat Holdings Pomerantz LLP has announced that a class action lawsuit has been initiated against Red Cat Holdings, Inc. (RCAT) and certain officers due to allegations of misconduct. The legal action is filed in the United States District Court for the District of New Jersey. This lawsuit represents a class of individuals or entities...

Continue Reading
IPVanish: The Ultimate Solution for Cloud Storage Security

Updated Category News Views 129

IPVanish: Leading the Charge in Cloud Security As more individuals and businesses migrate to the cloud, the urgency for secure storage solutions has skyrocketed. IPVanish has stepped up to become a standout player in this landscape, recognized for its outstanding cloud access tools and strong privacy measures. Transformation into a Comprehensive Security Platform...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 11

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading
Investors Anticipate Earnings from Booz Allen Hamilton Soon

Updated Category News Views 134

Market Expectations for Booz Allen Hamilton's Earnings Booz Allen Hamilton (NYSE: BAH) is set to unveil its quarterly earnings soon, and it's important for investors to be well-prepared. Analysts anticipate an earnings per share (EPS) of $1.51, a key figure to watch as it could impact stock sentiment significantly. Performance Insights and Analyst Predictions The hope...

Continue Reading
USD/JPY Holds Steady Amid Economic Shifts and Data Releases

Updated Category News Views 124

USD/JPY Stabilizes After Inflation Adjustments The USD/JPY currency pair has recently stabilized after a brief drop below the key level of 141.77. This dip happened just before the US Consumer Price Index (CPI) was announced, revealing an inflation rate of 2.5%. Following this data release, the currency pair started to rebound, thanks in part to a slight increase in US...

Continue Reading